HALOZYME THERAPEUTICS, INC. - COM (HALO)

Q2 2018 13F Holders as of 6/30/2018

Type / Class
Equity / COM
Number of holders
193
Total Shares
123M
Shares change
-800K
Total reported value, excl. options
$2.07B
Value change
-$21.2M
Put/Call ratio
0.59
Number of buys
85
Number of sells
-101
Price
$16.87
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.